| 2026-08-05 | 10-Q | 10.1 | EXHIBIT 10.1 - FORM OF ELANCO RESTRICTED STOCK UNIT |
|---|
| 2026-05-06 | 10-Q | 10.5 | EXHIBIT 10.5 - FORM OF ELANCO RESTRICTED STOCK UNIT |
|---|
| 2026-05-06 | 10-Q | 10.4 | EXHIBIT 10.4 - FORM OF ELANCO RESTRICTED STOCK UNIT |
|---|
| 2026-05-06 | 10-Q | 10.3 | EXHIBIT 10.3 - FORM OF ELANCO PERFORMANCE-BASED AWARD AGREEMENT |
|---|
| 2026-05-06 | 10-Q | 10.2 | EXHIBIT 10.2 - FORM OF ELANCO NONQUALIFIED STOCK OPTION AWARD AGREEMENT |
|---|
| 2026-05-06 | 10-Q | 10.1 | EXHIBIT 10.1 - ELANCO AMENDED CORPORATE BONUS PLAN |
|---|
| 2026-02-24 | 10-K | 10.31 | EXHIBIT 10.31 ELANCO DIRECTOR DEFERRAL PLAN |
|---|
| 2025-11-03 | 8-K | 10.1 | Amendment No. 3, dated as of October 31, 2025, to the Credit Agreement, dated as of August 1, 2020, by and among Elanco Animal Health Incorporated, as borrower, Elanco US Inc., as co-borrower, Elanco Financing (Netherlands) B.V., as Dutch borrower, the subsidiary loan parties party thereto, the lenders and issuing banks party thereto from time to time, JPMorgan Chase Bank, N.A., as administrative agent and U.S. and Canadian collateral agent and Wilmington Trust, National Association, as non-U.S. and non-Canadian collateral agent and security trustee. |
|---|
| 2025-06-26 | 8-K | 10.1 | First Amendment to Receivables Loan Agreement by and among Elanco Animal Health Incorporated, solely in its role as performance guarantor, Elanco SPEAR LLC, as borrower, Elanco US Inc., as servicer, Coöperatieve Rabobank U.A., New York Branch, as Administrative Agent, and the lenders from time to time party thereto. |
|---|
| 2025-05-28 | 8-K | 10.2 | Transition Agreement, dated as of May 21, 2025, between Elanco Animal Health Incorporated and Todd Young. |
|---|
| 2025-05-28 | 8-K | 10.1 | Employment Offer Letter, dated as of May 20, 2025, between Elanco Animal Health Incorporated and Robert VanHimbergen. |
|---|
| 2025-05-07 | 10-Q | 10.5 | EX-10.5 FORM OF ELANCO RESTRICTED STOCK UNIT |
|---|
| 2025-05-07 | 10-Q | 10.4 | EX-10.4 FORM OF ELANCO RESTRICTED STOCK UNIT |
|---|
| 2025-05-07 | 10-Q | 10.3 | EX-10.3 FORM OF ELANCO PERFORMANCE-BASED AWARD AGREEMENT |
|---|
| 2025-05-07 | 10-Q | 10.2 | EX-10.2 FORM OF ELANCO NONQUALIFIED STOCK OPTION AWARD AGREEMENT |
|---|
| 2025-05-07 | 10-Q | 10.1 | EX-10.1 ELANCO AMENDED CORPORATE BONUS PLAN |
|---|
| 2025-02-25 | 10-K | 10.25 | EXHIBIT 10.25 - ELANCO STOCK PLAN OMNIBUS AMENDMENT TO STOCK OPTION AGREEMENTS |
|---|
| 2025-02-25 | 10-K | 10.24 | EXHIBIT 10.24 - FORM OF ELANCO PERFORMANCE-BASED AWARD AGREEMENT |
|---|
| 2025-02-25 | 10-K | 10.23 | EXHIBIT 10.23 - FORM OF ELANCO RESTRICTED STOCK UNIT AWARD AGREEMENT |
|---|
| 2025-02-25 | 10-K | 10.22 | EXHIBIT 10.22 - FORM OF ELANCO NONQUALIFIED STOCK OPTION AWARD AGREEMENT |
|---|
| 2025-02-25 | 10-K | 10.16 | EXHIBIT 10.16 - ELANCO AMENDED AND RESTATED CORPORATE BONUS PLAN |
|---|
| 2025-02-25 | 10-K | 10.13 | EXHIBIT 10.13 - FORM OF ELANCO SIGN-ON RESTRICTED STOCK UNIT AWARD AGREEMENT |
|---|
| 2025-02-25 | 10-K | 10.12 | EXHIBIT 10.12 - ELANCO EXECUTIVE DEFERRAL AND STOCK MATCH PLAN |
|---|
| 2024-08-13 | 8-K | 10.1 | Incremental Assumption Agreement dated August 13, 2024 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit Mid-America, PCA, as incremental term lender, and Goldman Sachs Bank USA, as the term facility agent. |
|---|
| 2024-07-03 | 8-K | 10.1 | Amendment No. 2, dated as of July 3, 2024, to the Credit Agreement, dated as of August 1, 2020, by and among Elanco Animal Health Incorporated, as borrower, Elanco US Inc., as co-borrower, the subsidiary loan parties party thereto, the lenders and issuing banks party thereto from time to time, Goldman Sachs Bank USA, as term facility agent, collateral agent and security trustee, and JPMorgan Chase Bank, N.A., as revolving facility agent. |
|---|
| 2024-04-01 | 8-K | 10.1 | Cooperation Agreement, dated as of March 29, 2024, by and among Elanco Animal Health Incorporated, Ancora Catalyst Institutional, LP and the other person and entities listed thereto. |
|---|
| 2023-08-07 | 8-K | 10.1 | Receivables Loan Agreement among Elanco SPEAR LLC, Elanco US Inc., The Various Lenders and Lender Agents from Time to Time Party Thereto and Coöperatieve Rabobank U.A., New York Branch, dated as of August 3, 2023 |
|---|
| 2023-03-01 | 10-K | 10.27 | Form of Elanco Animal Health Incorporated Nonqualified Stock Option Award Agreement for executives with respect to annual awards (filed herewith).* |
|---|
| 2023-03-01 | 10-K | 10.26 | Form of Elanco Animal Health Incorporated Performance-Based Award Agreement for executives with respect to annual awards (filed herewith).* |
|---|
| 2023-03-01 | 10-K | 10.25 | Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards (filed herewith).* |
|---|
| 2023-03-01 | 10-K | 10.23 | Elanco Animal Health Incorporated Amended and Restated Corporate Bonus Plan (filed herewith).* |
|---|
| 2022-08-08 | 10-Q | 10.1 | Consulting Agreement, dated April 12, 2022, by and between Aaron Schacht and Elanco US Inc. (filed herewith). |
|---|
| 2022-06-29 | 8-K | 10.1 | Incremental Assumption Agreement dated June 28, 2022 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Bank of America, N.A., as incremental term lender, each other person party thereto as incremental term lender, and Goldman Sachs Bank USA, as the term facility agent. |
|---|
| 2022-05-19 | 8-K | 10.1 | Elanco Animal Health Incorporated Amended and Restated Employee Stock Purchase Plan. |
|---|
| 2022-04-20 | 8-K | 10.1 | Incremental Assumption Agreement dated April 19, 2022 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit Mid-America, PCA, as incremental term lender, and Goldman Sachs Bank USA, as the term facility agent. |
|---|
| 2022-02-28 | 10-K | 10.17 | Services Agreement, dated as of January 1, 2022, by and between MBRD Service Company and Elanco US Inc. (filed herewith).* |
|---|
| 2021-08-12 | 8-K | 10.1 | Incremental Assumption Agreement dated August 12, 2021 by and among Elanco Animal Health Incorporated, Elanco US Inc., the subsidiary loan parties party thereto, Farm Credit Mid-America, PCA, as incremental term lender and Goldman Sachs Bank USA, as the term facility agent. |
|---|
| 2021-05-21 | 8-K | 10.1 | Elanco Animal Health Incorporated Amended and Restated 2018 Elanco Stock Plan (including related form agreements). |
|---|
| 2021-05-07 | 10-Q | 10.3 | Elanco Animal Health Incorporated Corporate Bonus Plan (filed herewith). |
|---|
| 2021-05-07 | 10-Q | 10.2 | Form of Elanco Animal Health Incorporated Performance-Based Restricted Stock Unit Award Agreement for executives with respect to annual awards (filed herewith). |
|---|
| 2021-05-07 | 10-Q | 10.1 | Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards (filed herewith). |
|---|
| 2021-03-01 | 10-K | 10.31 | Elanco Executive Severance Pay Plan and Summary (filed herewith)* |
|---|
| 2020-08-03 | 8-K | 10.1 | Credit Agreement, dated as of August 1, 2020, among Elanco Animal Health Incorporated, as borrower, Elanco US Inc., as co-borrower, the lenders party thereto from time to time, Goldman Sachs Bank USA, as term loan administrative agent, and as collateral agent and security trustee, and JPMorgan Chase Bank, N.A., as revolver administrative facility agent. |
|---|
| 2020-05-07 | 10-Q | 10.4 | Form of Elanco Animal Health Incorporated Sign-On Restricted Stock Unit Award Agreement for executives (filed herewith) |
|---|
| 2020-05-07 | 10-Q | 10.3 | Elanco Animal Health Incorporated Corporate Bonus Plan (filed herewith). |
|---|
| 2020-05-07 | 10-Q | 10.2 | Form of Elanco Animal Health Incorporated Performance-Based Award Agreement for executives with respect to annual awards (filed herewith). |
|---|
| 2020-05-07 | 10-Q | 10.1 | Form of Elanco Animal Health Incorporated Restricted Stock Unit Award Agreement for executives with respect to annual awards (filed herewith) |
|---|
| 2019-12-20 | 8-K | 10.2 | First Amendment to Term Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as administrative agent and the other Lenders party thereto. |
|---|
| 2019-12-20 | 8-K | 10.1 | First Amendment to Revolving Loan Credit Agreement, dated as of September 5, 2018, among Elanco Animal Health Incorporated, as borrower, JPMorgan Chase Bank, N.A., as administrative agent and the other Lenders party thereto. |
|---|
| 2019-08-13 | 10-Q | 10.1 | ELANCO ANIMAL HEALTH DIRECTORS DEFERRAL PLAN |
|---|
| 2019-05-14 | 10-Q | 10.4 | ELANCO ANIMAL HEALTH REPLACEMENT RSU AGREEMENT |
|---|
| 2019-05-14 | 10-Q | 10.3 | ELANCO ANIMAL HEALTH DIRECTORS FOUNDERS AWARDS |
|---|
| 2019-05-14 | 10-Q | 10.2 | ELANCO ANIMAL HEALTH DIRECTORS ANNUAL GRANTS |
|---|
| 2019-05-14 | 10-Q | 10.1 | ELANCO ANIMAL HEALTH DIRECTORS DEFERRAL PLAN |
|---|
| 2019-02-20 | 10-K | 10.25 | Form of Replacement Restricted Stock Unit Award Agreement for Certain Named Executive Officers (filed herewith)* |
|---|
| 2019-02-20 | 10-K | 10.24 | Form of Replacement Performance Award Agreement for Jeffery N. Simmons (filed herewith)* |
|---|
| 2019-02-20 | 10-K | 10.23 | Form of Replacement Performance Award Agreement for Certain Named Executive Officers (filed herewith)* |
|---|
| 2019-02-20 | 10-K | 10.22 | Form of Restricted Stock Unit Award Agreement (filed herewith)* |
|---|
| 2019-02-19 | 8-K | 10.2 | Form of RSU Agreement |
|---|
| 2019-02-19 | 8-K | 10.1 | Form of Performance Award Agreement |
|---|
| 2018-10-30 | 8-K | 10.2 | Retention Bonus Agreement |
|---|
| 2018-10-30 | 8-K | 10.1 | October 15, 2018 |
|---|
| 2018-09-26 | 8-K | 10.8 | Intellectual Property and Technology License Agreement, dated September 24, 2018, among Eli Lilly and Company, Elanco Animal Health Incorporated and Elanco US Inc. |
|---|
| 2018-09-26 | 8-K | 10.7 | Transitional Trademark License Agreement, dated September 24, 2018, among Eli Lilly and Company, Elanco Animal Health Incorporated and Elanco US Inc. |
|---|
| 2018-09-26 | 8-K | 10.6 | Registration Rights Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated |
|---|
| 2018-09-26 | 8-K | 10.5 | Toll Manufacturing and Supply Agreement, dated September 24, 2018, between Eli Lilly Export S.A. and Elanco UK AH Limited |
|---|
| 2018-09-26 | 8-K | 10.4 | Employee Matters Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated |
|---|
| 2018-09-26 | 8-K | 10.3 | Tax Matters Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated |
|---|
| 2018-09-26 | 8-K | 10.2 | Transitional Services Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated |
|---|
| 2018-09-26 | 8-K | 10.1 | Master Separation Agreement, dated September 24, 2018, between Eli Lilly and Company and Elanco Animal Health Incorporated |
|---|